SHANGHAI, Aug. 31, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in advanced medical imaging and radiotherapy equipment, has released its 2024 half-year report, showcasing robust financial performance. The company achieved revenue of 5.33 billion CNY for H1 2024, marking a stable increase of 1.18%. Net income attributable to shareholders reached 0.95 billion CNY, reflecting a year-over-year (YoY) growth of 1.33%.
A significant contributor to this growth was MR, which generated 1.69 billion CNY in H1 2024. This underscores the company's strategic focus on its core business and the continued market leadership of its primary product lines. Led by Sean Wu, analysts at Morgan Stanley have expressed optimism about United Imaging's high sales visibility in equipment replacement, further reinforcing its strong market position.
In the first half of 2024, United Imaging Healthcare maintained its commitment to innovation, with R&D investments totaling 1.02 billion CNY—a YoY increase of 11.11%. These investments have led to the introduction of new products, including the uMR Jupiter 5T, the industry's first whole-body clinical ultra-high-field magnetic resonance system. This groundbreaking technology, cleared by the FDA under ...
